FFA
UTMD icon

Farther Finance Advisors’s Utah Medical Products UTMD Stock Holding History

Farther Finance Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Buy
27
+17
+170% +$1.13K ﹤0.01% 5188
2026
Q1 		$629 Sell
10
-14
-58% -$882 ﹤0.01% 5221
2025
Q4 		$1.34K Buy
24
+16
+200% +$927 ﹤0.01% 4826
2025
Q3 		$504 Buy
+8
New +$473 ﹤0.01% 4539
2024
Q4 		– Sell
-1
Closed -$67 – 4152
2024
Q3 		$67 Hold
1
– – ﹤0.01% 3839
2024
Q2 		$67 Buy
+1
New +$68 ﹤0.01% 3658

Other funds holding UTMD

CCMINC
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
PIM
Penobscot Investment Management Boston, Massachusetts $1.46B AUM 32.32% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Farther Finance Advisors's UTMD Position: Q2 2026 in Review

Farther Finance Advisors increased its Utah Medical Products (UTMD) stake by 170% in Q2 2026, buying an estimated $1.13K and bringing the position to 27 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #5188.

Farther Finance Advisors first reported a position in UTMD in Q2 2024 and has held it in 6 quarters since. 17 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Farther Finance Advisors held 27 shares of Utah Medical Products worth $1.87K as of Q2 2026.
  • Farther Finance Advisors bought 17 Utah Medical Products shares in Q2 2026, an estimated $1.13K.
  • Utah Medical Products made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5188 holding.
  • Farther Finance Advisors first reported a position in Utah Medical Products in Q2 2024 and has held it in 6 quarters since.
  • 17 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.